ArticleBMC cancer2026
Delays and detours during cancer diagnosis: a cross-sectional study on patient pathways and provider intervals in public healthcare networks of Chile, Colombia and Ecuador.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Estimated five-year survival and direct healthcare costs of adult patients with gastric cancer: real-world evidence from a tertiary hospital in Colombia.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe longest delays in cancer diagnosis in Latin America occur between the first contact with health services and the confirmation of diagnosis (referred to as the provider interval), yet few studies have examined patient pathways to understand these delays. This study aims to analyze patient diagnostic pathways and their relationship to the provider interval in public healthcare networks of Chile, Colombia and Ecuador.
methodsCross-sectional study based on questionnaire survey to adult patients diagnosed with cancer in prior 12 months in the study networks (n = 351 in Chile; 303 in Colombia; 365 in Ecuador). Study variables were diagnostic pathways (according to type and sequence of services) and provider intervals. Descriptive, bivariate and adjusted multivariate quantile regression analyses were conducted.
resultsTwo pathway types were identified: (a) public services use, frequent in Colombia (67.3%) and (b) mixed public-private services use, predominant in Chile (76.9%) and Ecuador (59.2%). Under 20% of patients followed the public pathway starting in primary care followed by referral to secondary care for confirmation. In Colombia and Ecuador, it was common to start in emergency departments, and in Colombia, going back and forth between care levels. Median provider interval was 111 days (IQR:134) in Chile, 156 (IQR:275) in Colombia and 92 (IQR:173) in Ecuador. Public-private pathways, more frequent in symptomatic patients, were significantly longer than public-only pathways (Chile: 116 vs. 92 days; Colombia: 175 vs. 153 days; Ecuador: 92 vs. 75 days; all p < 0.05). Emergency-initiated pathways were significantly shorter, whereas Colombia’s back-and-forth pathways were longer than those via primary care, although this difference was not statistically significant.
conclusionThe results reveal fragmented diagnostic pathways with significant delays, particularly in Colombia. The results underscore the need for equity-oriented policies to improve access to care in public healthcare networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.